Top Markets
#1 Black Phoenix Black Phoenix +2,485.28%
#2 Nesa Nesa +743.87%
#3 Ontology Gas Ontology Gas +141.61%
#4 ADO Protocol ADO Protocol +103.71%
#5 Cortex Cortex +95.45%
#6 Kinesis Silver Kinesis Silver +54.43%
#7 Magma Finance Magma Finance +34.30%
#8 Pons Pons +33.70%
#9 OpenEden OpenEden +33.50%
#10 Non-Playable Coin Non-Playable Coin +32.03%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Classificação em ações #18557
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Preço da ação
$0.15360289
Valor de mercado
$190.75M
Variação (1 dia)
6.25%
Variação (1 ano)
94.11%
País
NZ
Negociar Pacific Edge Limited (PEB)

Categoria

Healthcare
Histórico de rendimento de dividendos para Pacific Edge Limited (PEB)
O rendimento de dividendos (TTM) da Pacific Edge Limited (símbolo da ação: PEB) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Pacific Edge Limited (PEB) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
0.31%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
0.71%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
0.68%
US